Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
about
Detailed assessment of gene activation levels by multiple hypoxia-responsive elements under various hypoxic conditions.p53 activated by AND gate genetic circuit under radiation and hypoxia for targeted cancer gene therapy.Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression.Targeted molecular imaging in oncology: focus on radiation therapy.Study of the combined treatment of lung cancer using gene-loaded immunomagnetic albumin nanospheres in vitro and in vivoEvaluation of p21 promoter for interleukin 12 radiation induced transcriptional targeting in a mouse tumor model.Viral-based gene delivery and regulated gene expression for targeted cancer therapy.STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer.Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma.The radiation dose-regulated AND gate genetic circuit, a novel targeted and real-time monitoring strategy for cancer gene therapy.Radiation-inducible silencing of uPA and uPAR in vitro and in vivo in meningioma.Using HSV-TK/GCV suicide gene therapy to inhibit lens epithelial cell proliferation for treatment of posterior capsular opacification.Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy.Translation of the radio- and chemo-inducible TNFerade vector to the treatment of human cancers.Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis.
P2860
Q35789454-79D419C1-CBAF-4DE6-952A-D91F37413BD9Q36092864-220CF745-9272-429B-8A4E-A4D57D670897Q36431079-643A7054-EBC7-4E65-BD9A-A405E810E224Q36528175-4FC7A3CC-3AD8-4E10-A48A-9D3EF76B07AAQ36710252-8A29A01F-1F4D-43A9-A65B-239E9682F663Q37322120-5C4C9C84-2206-4AD8-9E22-374357519D3AQ37641366-90C9B079-1DDA-44FC-AB8F-9D6F0A01592BQ37668555-654033C4-310B-4A89-8DCC-DA80A62A997CQ37818222-9FBBFF84-FEE1-4113-842D-548D9EDE1344Q39365194-3427300E-8D9E-41A5-881F-F8B645D5A8D3Q39589853-C3BD25B5-4091-4A13-B44D-4B44245FF636Q39599730-2F1AB6A3-61B3-4E23-8CE0-1368EEF15E8BQ41925534-D673FEF9-D0BD-4C9C-8B39-12CB3F41D162Q45885293-81FF5F2D-0A14-43DE-8358-E4BD900C2182Q45887307-50A9E788-E9D4-4C33-8CDC-4632D9403ACC
P2860
Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Hypoxia- and radiation-activat ...... rs for gene therapy of cancer.
@en
Hypoxia- and radiation-activat ...... rs for gene therapy of cancer.
@nl
type
label
Hypoxia- and radiation-activat ...... rs for gene therapy of cancer.
@en
Hypoxia- and radiation-activat ...... rs for gene therapy of cancer.
@nl
prefLabel
Hypoxia- and radiation-activat ...... rs for gene therapy of cancer.
@en
Hypoxia- and radiation-activat ...... rs for gene therapy of cancer.
@nl
P2093
P2860
P356
P1433
P1476
Hypoxia- and radiation-activat ...... ors for gene therapy of cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3302640
P577
2006-02-01T00:00:00Z
P5875
P6179
1008270617